Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - ENANTA PHARMACEUTICALS INC | enta-ex321_9.htm |
| EX-31.2 - EX-31.2 - ENANTA PHARMACEUTICALS INC | enta-ex312_11.htm |
| EX-31.1 - EX-31.1 - ENANTA PHARMACEUTICALS INC | enta-ex311_10.htm |
| EX-21.1 - EX-21.1 - ENANTA PHARMACEUTICALS INC | enta-ex211_13.htm |
| EX-10.10 - EX-10.10 - ENANTA PHARMACEUTICALS INC | enta-ex1010_399.htm |
| 10-K - 10-K - ENANTA PHARMACEUTICALS INC | enta-10k_20180930.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S‑8 (Nos. 333-189217, 333-192935, 333-202257, 333-209542, 333-215011, and 333-221988) of Enanta Pharmaceuticals, Inc. of our report dated November 29, 2018 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
November 29, 2018